Question 1

Am I eligible for this trial based on my previous treatments and current health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CAR-T Followed by Bispecific Antibodies clinical trial (NCT04889716). Contact the study team or your healthcare provider for specific answers.

Question 2

How do the potential side effects of mosunetuzumab and glofitamab compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CAR-T Followed by Bispecific Antibodies clinical trial (NCT04889716). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CAR-T Followed by Bispecific Antibodies clinical trial (NCT04889716). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will be done during the trial to ensure my safety?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CAR-T Followed by Bispecific Antibodies clinical trial (NCT04889716). Contact the study team or your healthcare provider for specific answers.

Question 5

How might participating in this trial affect my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CAR-T Followed by Bispecific Antibodies clinical trial (NCT04889716). Contact the study team or your healthcare provider for specific answers.

What this study is about